Agenda for Day 4 – Friday November 20, 2026Friday, 20 November 2026

As more injectable therapies move into the home, manufacturers are assuming an often-overlooked risk, what happens to used sharps after the dose is delivered. Most patient support programs stop at therapy access, yet improper at-home disposal introduces safety exposure, diversion concerns, regulatory variability and potential brand liability.

• In this session, take a deep dive into three key areas.

• Risk Mitigation for Manufacturers: Needle-stick exposure in the home, diversion risk and the patchwork of state disposal regulations – and how manufacturer-sponsored mail-back programs reduce compliance and liability concerns

• Impact on Patient Experience & Adherence: The emotional and practical burden self-injecting patients face when storing used sharps, and how integrated disposal improves confidence, satisfaction and therapy continuity

• The Strategic Business Case: Why forward-thinking brands are embedding compliant sharps mail-back programs into HUB and patient support models, not as a cost center, but as a brand protection, ESG, and competitive differentiation strategy

As the role of Field Reimbursement Managers (FRMs) evolves, organizations must reassess their strategies to define the purpose of field teams, align their activities with product-specific needs and evaluate the necessity of field-facing roles in areas with strong coverage. Explore how to empower FRMs to deliver value while maintaining compliance and adapting to changing operational demands.

• Gain clarity on how to tailor field team activities to the unique requirements of each product and market

• Learn how to redirect focus toward other high-impact activities, such as patient education, provider engagement or data collection, to maximize value

• Address the critical question, “Do we need field-facing roles in areas with strong coverage?” Examine the factors that influence this decision, including market dynamics, product lifecycle and patient support needs to determine the most effective deployment of resources

• Discover best practices for empowering FRMs to operate effectively while adhering to compliance guidelines

Explore the latest data privacy considerations impacting copay models, including state-specific legislation, compliance requirements, and strategies for managing Patient Health Information (PHI). Gain insights into how manufacturers can leverage data responsibly to enhance patient services while adhering to privacy regulations.

• Review state-enacted privacy legislations and their implications for copay data storage and usage compliance

• Understand permissible data access for manufacturers and learn how to use this data to improve patient services effectively

• Develop strategies to address firewalls surrounding PHI and ensure HIPAA compliance, including proper patient service form signatures

The Trump Rx initiative has introduced a new dynamic to the direct-to-patient conversation, offering cash-price access that puts control in patients' hands. Examine how Trump Rx is reshaping the DTP landscape and explore how manufacturers are approaching opt-in decisions, advertising strategies and program design as they navigate a future where cash-price alternatives may coexist or disrupt traditional insurance-based access.

• Gain clarity on how Trump Rx actually works and what it means for patient support and access

• Explore how different pharmaceutical manufacturers are approaching Trump Rx participation and promotion

As patient support programs expand and Field Reimbursement Manager (FRM) teams grow, the challenge shifts from individual effectiveness to scalable systems that maintain quality and collaboration. Explore how leading organizations are managing FRM team growth, optimizing and strengthening critical partnerships with stakeholders.

• Hear strategies for scaling FRM teams effectively as programs expand, including optimal deployment methods tailored to specific product and market needs

• Discover how successful field reimbursement managers are forging production partnerships with Medical Science Liaison (MSL) teams and other key stakeholders, while defining clear swim lanes within the broader patient support ecosystem

• Explore best practices for how patient support, hubs and centralized operations can effectively work with field teams, ensuring seamless handoffs to specialty pharmacies and navigators for fewer touchpoints

• Understand how sales teams can adopt a holistic approach to access, engaging with patients, physicians, case managers and pharmacists to support treatment journeys

In a year of unprecedented change in the patient support industry, what has happened and what does it mean for the future of the patient experience. A comprehensive guide to forging ahead.

• Join industry leaders as we explore the trends shaping the patient experience, services, investments and partnerships while recognizing the best-in-class programs driving the industry forward

Join us for an exclusive AI Innovation Spotlight during lunch, featuring cutting-edge vendors delivering rapid-fire pitches on transformative AI solutions for patient support programs. Discover the latest technologies reshaping patient engagement and explore practical AI applications that could revolutionize your approach to patient support.

Manufacturers are continuing to grapple with an ever-evolving healthcare landscape, especially when it comes to balancing affordability with patient needs. Delve into innovative strategies for navigating gross-to-net challenges and keeping patients at the forefront of decision-making.

• Hear how to ensure equitable and sustainable solutions - finding that balance between patient access and cost management

• Address industry challenges such as benefit design complexity, accumulator programs and evolving regulations

Take a rare opportunity to step into the payer mindset, understand what truly motivates their decisions and identify where collaboration can replace confrontation. 

• Gain a deeper understanding of why payers create the barriers they do - from prior authorization requirements to formulary restrictions - and learn what they actually care about beyond cost 

• Assess proven approaches for helping patients overcome prior authorization delays, step therapy protocols and specialty pharmacy mandates 

• Explore where collaboration opportunities exist between manufacturers and payers - value-based contracting models, outcomes-based agreements and data-sharing agreements that can reduce barriers

• Identify strategies to hire people with the right skill set and understand the staffing model that is needed for your patient population

• Learn how to put together robust and comprehensive training schedules

• Ensure that your team remains compliant